vs

Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and System1, Inc. (SST). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $51.9M, roughly 1.5× System1, Inc.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -31.3%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -21.8%).

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

System1 is an American Internet advertising company. Formerly known as OpenMail, it was founded in 2013. It describes itself as operating a "Responsive Acquisition Marketing Platform", and cites privacy as one of its principal foci, although it has been criticized for its influence on privacy-focused properties, including search engine Startpage.com. It is headquartered in Marina del Rey, California.

PBYI vs SST — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.5× larger
PBYI
$75.5M
$51.9M
SST
Growing faster (revenue YoY)
PBYI
PBYI
+59.0% gap
PBYI
27.7%
-31.3%
SST
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
-21.8%
SST

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PBYI
PBYI
SST
SST
Revenue
$75.5M
$51.9M
Net Profit
$-13.5M
Gross Margin
69.3%
41.0%
Operating Margin
22.7%
-33.6%
Net Margin
-26.0%
Revenue YoY
27.7%
-31.3%
Net Profit YoY
4.8%
EPS (diluted)
$0.26
$-3.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PBYI
PBYI
SST
SST
Q4 25
$75.5M
$51.9M
Q3 25
$54.5M
$61.6M
Q2 25
$52.4M
$78.1M
Q1 25
$46.0M
$74.5M
Q4 24
$59.1M
$75.6M
Q3 24
$80.5M
$88.8M
Q2 24
$47.1M
$94.6M
Q1 24
$43.8M
$84.9M
Net Profit
PBYI
PBYI
SST
SST
Q4 25
$-13.5M
Q3 25
$8.8M
$-18.5M
Q2 25
$5.9M
$-17.5M
Q1 25
$3.0M
$-15.9M
Q4 24
$-14.2M
Q3 24
$20.3M
$-23.6M
Q2 24
$-4.5M
$-26.4M
Q1 24
$-4.8M
$-10.5M
Gross Margin
PBYI
PBYI
SST
SST
Q4 25
69.3%
41.0%
Q3 25
77.7%
36.9%
Q2 25
76.5%
35.7%
Q1 25
77.1%
38.2%
Q4 24
76.4%
42.1%
Q3 24
63.9%
28.0%
Q2 24
77.4%
27.6%
Q1 24
75.5%
21.9%
Operating Margin
PBYI
PBYI
SST
SST
Q4 25
22.7%
-33.6%
Q3 25
17.6%
-25.3%
Q2 25
12.7%
-20.4%
Q1 25
8.7%
-17.6%
Q4 24
22.6%
-15.7%
Q3 24
27.4%
-24.6%
Q2 24
-4.6%
-30.8%
Q1 24
-5.3%
-30.4%
Net Margin
PBYI
PBYI
SST
SST
Q4 25
-26.0%
Q3 25
16.2%
-30.1%
Q2 25
11.2%
-22.4%
Q1 25
6.5%
-21.3%
Q4 24
-18.7%
Q3 24
25.2%
-26.6%
Q2 24
-9.6%
-27.9%
Q1 24
-11.0%
-12.4%
EPS (diluted)
PBYI
PBYI
SST
SST
Q4 25
$0.26
$-3.58
Q3 25
$0.17
$-2.30
Q2 25
$0.12
$-2.23
Q1 25
$0.06
$-0.21
Q4 24
$0.40
$-3.41
Q3 24
$0.41
$-3.37
Q2 24
$-0.09
$-3.80
Q1 24
$-0.10
$-0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PBYI
PBYI
SST
SST
Cash + ST InvestmentsLiquidity on hand
$97.5M
$86.9M
Total DebtLower is stronger
$22.7M
$305.1M
Stockholders' EquityBook value
$130.3M
$30.5M
Total Assets
$216.3M
$405.0M
Debt / EquityLower = less leverage
0.17×
10.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PBYI
PBYI
SST
SST
Q4 25
$97.5M
$86.9M
Q3 25
$94.4M
$54.6M
Q2 25
$96.0M
$63.6M
Q1 25
$93.2M
$43.9M
Q4 24
$101.0M
$63.6M
Q3 24
$96.7M
$69.1M
Q2 24
$96.8M
$75.7M
Q1 24
$107.2M
$69.9M
Total Debt
PBYI
PBYI
SST
SST
Q4 25
$22.7M
$305.1M
Q3 25
$34.0M
$259.2M
Q2 25
$45.3M
$263.3M
Q1 25
$56.7M
$267.4M
Q4 24
$68.0M
$255.1M
Q3 24
$79.3M
$259.2M
Q2 24
$90.7M
$263.3M
Q1 24
$102.0M
$268.6M
Stockholders' Equity
PBYI
PBYI
SST
SST
Q4 25
$130.3M
$30.5M
Q3 25
$115.3M
$42.7M
Q2 25
$104.7M
$58.2M
Q1 25
$97.1M
$67.2M
Q4 24
$92.1M
$80.3M
Q3 24
$71.1M
$90.3M
Q2 24
$48.5M
$109.4M
Q1 24
$51.0M
$131.7M
Total Assets
PBYI
PBYI
SST
SST
Q4 25
$216.3M
$405.0M
Q3 25
$202.9M
$385.2M
Q2 25
$194.9M
$429.2M
Q1 25
$196.2M
$419.2M
Q4 24
$213.3M
$459.1M
Q3 24
$220.7M
$479.3M
Q2 24
$205.0M
$511.3M
Q1 24
$214.1M
$521.1M
Debt / Equity
PBYI
PBYI
SST
SST
Q4 25
0.17×
10.01×
Q3 25
0.30×
6.07×
Q2 25
0.43×
4.53×
Q1 25
0.58×
3.98×
Q4 24
0.74×
3.18×
Q3 24
1.12×
2.87×
Q2 24
1.87×
2.41×
Q1 24
2.00×
2.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PBYI
PBYI
SST
SST
Operating Cash FlowLast quarter
$14.4M
$-10.6M
Free Cash FlowOCF − Capex
$14.4M
FCF MarginFCF / Revenue
19.1%
Capex IntensityCapex / Revenue
0.0%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PBYI
PBYI
SST
SST
Q4 25
$14.4M
$-10.6M
Q3 25
$9.7M
$-2.1M
Q2 25
$14.1M
$24.5M
Q1 25
$3.6M
$-15.9M
Q4 24
$15.6M
$772.0K
Q3 24
$11.0M
$-5.0K
Q2 24
$1.0M
$10.0M
Q1 24
$11.2M
$-16.0M
Free Cash Flow
PBYI
PBYI
SST
SST
Q4 25
$14.4M
Q3 25
$9.7M
Q2 25
$14.1M
Q1 25
$3.6M
$-16.0M
Q4 24
$15.6M
Q3 24
$11.0M
$-36.0K
Q2 24
$1.0M
Q1 24
FCF Margin
PBYI
PBYI
SST
SST
Q4 25
19.1%
Q3 25
17.7%
Q2 25
26.8%
Q1 25
7.7%
-21.5%
Q4 24
26.4%
Q3 24
13.7%
-0.0%
Q2 24
2.1%
Q1 24
Capex Intensity
PBYI
PBYI
SST
SST
Q4 25
0.0%
0.0%
Q3 25
0.0%
0.0%
Q2 25
0.0%
0.0%
Q1 25
0.1%
0.1%
Q4 24
0.0%
0.0%
Q3 24
0.0%
0.0%
Q2 24
0.0%
0.0%
Q1 24
0.0%
0.0%
Cash Conversion
PBYI
PBYI
SST
SST
Q4 25
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.54×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons